Altered Kynurenine Pathway Metabolism in Rats Fed Added Sugars

Aim: The consumption of added sugars containing fructose has increased dramatically. Various studies have revealed that added sugar consumption may be involved in the pathogenesis of cardiovascular, metabolic and neurocognitive disorders by triggering subclinical inflammation. The imbalance in the k...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genel tip dergisi 2022-10, Vol.32 (5), p.525-529
Hauptverfasser: OZTURK, Bahadir, ERYAVUZ ONMAZ, Duygu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: The consumption of added sugars containing fructose has increased dramatically. Various studies have revealed that added sugar consumption may be involved in the pathogenesis of cardiovascular, metabolic and neurocognitive disorders by triggering subclinical inflammation. The imbalance in the kynurenine pathway metabolites may be associated with inflammation and oxidative stress. The aim of this study is to investigate the effect of HFCS-55, invert sugar and sucrose intervention on the kynurenine pathway metabolite levels (tryptophan, kynurenine, 3-hydroxykynurenine, 3-hydroxyanthranilic acid, quinolinic acid and kynurenic acid) in Wistar rats. Material and Methods: Twenty-four Wistar male rats (8-12 weeks old, weighting 300-350 g) were included in the study. After one week of conditioning, the animals were randomly divided into four groups: chow diet and tap water (control, n = 6), chow diet and tap water including 10% HFCS-55 (55% sucrose, 45% glucose), chow diet and tap water including 10% sucrose, chow diet and tap water including 10% invert sugar (33% sucrose, 66% glucose and fructose). At the end of the 3-month experimental period, serum kynurenines levels were measured by tandem mass spectrometry. Results: Serum kynurenine levels and kynurenine / tryptophan ratio were significantly higher (p
ISSN:2602-3741
2602-3741
DOI:10.54005/geneltip.1140308